• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pulmonary capillary leak syndrome following COVID-19 virus infection.

作者信息

Bahloul Mabrouk, Ketata Wajdi, Lahyeni Dorra, Mayoufi Houda, Kotti Amina, Smaoui Fatma, Kallel Nessrine, Daoud Emna, Bouaziz Mounir, Kammoun Samy

机构信息

Department of Intensive Care, HabibBourguiba University Hospital, Faculté de medicine de sfax, Sfax University, Sfax, Tunisia.

Department of Pneumology, Hedi Chaker University Hospital, Faculté de medicine de sfax, Sfax University, Sfax, Tunisia.

出版信息

J Med Virol. 2021 Jan;93(1):94-96. doi: 10.1002/jmv.26152. Epub 2020 Jun 29.

DOI:10.1002/jmv.26152
PMID:32519786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7300440/
Abstract
摘要

相似文献

1
Pulmonary capillary leak syndrome following COVID-19 virus infection.新型冠状病毒肺炎病毒感染后的肺毛细血管渗漏综合征
J Med Virol. 2021 Jan;93(1):94-96. doi: 10.1002/jmv.26152. Epub 2020 Jun 29.
2
A case of chronic systemic capillary leak syndrome (SCLS) exacerbated during SARS-CoV2 infection.一例慢性全身毛细血管渗漏综合征（SCLS）在 SARS-CoV2 感染期间加重。
Eur Rev Med Pharmacol Sci. 2021 Oct;25(19):5922-5927. doi: 10.26355/eurrev_202110_26868.
3
Successful management of coronavirus disease 2019-associated myocardial injury and capillary leak syndrome: A case report.2019冠状病毒病相关心肌损伤和毛细血管渗漏综合征的成功管理：一例报告
ESC Heart Fail. 2024 Oct;11(5):3457-3462. doi: 10.1002/ehf2.14914. Epub 2024 Jun 19.
4
SARS-CoV-2 Induces Acute and Refractory Relapse of Systemic Capillary Leak Syndrome (Clarkson's Disease).严重急性呼吸综合征冠状病毒2引发全身性毛细血管渗漏综合征（克拉克森病）的急性和难治性复发。
Am J Med. 2020 Nov;133(11):e663-e664. doi: 10.1016/j.amjmed.2020.03.057. Epub 2020 May 13.
5
Fatal Exacerbations of Systemic Capillary Leak Syndrome Complicating Coronavirus Disease.冠状病毒病并发全身性毛细血管渗漏综合征的致死性加重。
Emerg Infect Dis. 2021 Oct;27(10):2529-2534. doi: 10.3201/eid2710.211155. Epub 2021 Jul 27.
6
Pulmonary capillary leak syndrome after influenza A (H1N1) virus infection.
Am J Emerg Med. 2010 Nov;28(9):1063.e1-6. doi: 10.1016/j.ajem.2010.01.033. Epub 2010 May 4.
7
Hypoalbuminemia in COVID-19: assessing the hypothesis for underlying pulmonary capillary leakage.COVID-19 中的低白蛋白血症：评估潜在肺毛细血管渗漏假说。
J Intern Med. 2021 Jun;289(6):861-872. doi: 10.1111/joim.13208. Epub 2021 Jan 7.
8
Systemic capillary leak syndrome after SARS-CoV-2 infection and after COVID-19 vaccination: A scoping review in relation to a clinical case.新型冠状病毒2感染后及新型冠状病毒肺炎疫苗接种后的系统性毛细血管渗漏综合征：与一例临床病例相关的范围综述
Rev Clin Esp (Barc). 2022 Jun-Jul;222(6):374-376. doi: 10.1016/j.rceng.2021.11.005. Epub 2022 Feb 28.
9
Systemic Capillary Leak Syndrome Secondary to Coronavirus Disease 2019.全身性毛细血管渗漏综合征继发于 2019 年冠状病毒病。
Chest. 2020 Dec;158(6):e267-e268. doi: 10.1016/j.chest.2020.06.049. Epub 2020 Jul 3.
10
Severe Exacerbations of Systemic Capillary Leak Syndrome After COVID-19 Vaccination: A Case Series.新冠病毒疫苗接种后发生的全身性毛细血管渗漏综合征严重加重：病例系列
Ann Intern Med. 2021 Oct;174(10):1476-1478. doi: 10.7326/L21-0250. Epub 2021 Jun 15.

引用本文的文献

1
IgM has a better relative distribution in inflammation sites and tumor tissues than IgG.与IgG相比，IgM在炎症部位和肿瘤组织中的相对分布更佳。
J Nanobiotechnology. 2025 Mar 28;23(1):253. doi: 10.1186/s12951-025-03213-4.
2
Ultrasound findings and specific intrinsic blood volume expansion therapy for neonatal capillary leak syndrome: report from a multicenter prospective self-control study.新生儿毛细血管渗漏综合征的超声表现及特异性固有血容量扩充治疗：多中心前瞻性自身对照研究报告。
Eur J Med Res. 2024 Mar 1;29(1):150. doi: 10.1186/s40001-024-01738-2.
3
Therapeutic Polypeptides and Peptidomimetics: Powerful Tools for COVID-19 Treatment.治疗性多肽和类肽：COVID-19 治疗的有力工具。
Clin Drug Investig. 2023 Jan;43(1):13-22. doi: 10.1007/s40261-022-01231-w. Epub 2022 Dec 3.
4
Do we miss rare adverse events induced by COVID-19 vaccination?我们是否遗漏了由新冠病毒疫苗接种引起的罕见不良事件？
Front Med (Lausanne). 2022 Oct 10;9:933914. doi: 10.3389/fmed.2022.933914. eCollection 2022.
5
Idiopathic Systemic Capillary Leak Syndrome: A Rare Cause of Refractory Shock Following Influenza B Infection.特发性系统性毛细血管渗漏综合征：乙型流感感染后难治性休克的罕见病因。
J Community Hosp Intern Med Perspect. 2022 Jul 4;12(4):121-125. doi: 10.55729/2000-9666.1088. eCollection 2022.
6
Demographic Characteristics, Comorbidities, and Length of Stay of COVID-19 Patients Admitted Into Intensive Care Units in Saudi Arabia: A Nationwide Retrospective Study.沙特阿拉伯重症监护病房收治的COVID-19患者的人口统计学特征、合并症及住院时间：一项全国性回顾性研究
Front Med (Lausanne). 2022 Jul 13;9:893954. doi: 10.3389/fmed.2022.893954. eCollection 2022.
7
Prognostic Value of Serum Cholinesterase Activity in Severe SARS-CoV-2-Infected Patients Requiring Intensive Care Unit Admission.血清胆碱酯酶活性在需要入住重症监护病房的重症新型冠状病毒肺炎感染患者中的预后价值
Am J Trop Med Hyg. 2022 Jul 25;107(3):534-9. doi: 10.4269/ajtmh.21-0934.
8
Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation.长新冠：血栓后遗症的性质决定了早期抗凝的必要性。
Front Cell Infect Microbiol. 2022 Apr 5;12:861703. doi: 10.3389/fcimb.2022.861703. eCollection 2022.
9
The Effects of Vitamin C on the Multiple Pathophysiological Stages of COVID-19.维生素C对新型冠状病毒肺炎多病理生理阶段的影响
Life (Basel). 2021 Dec 3;11(12):1341. doi: 10.3390/life11121341.
10
Zinc for the prevention or treatment of acute viral respiratory tract infections in adults: a rapid systematic review and meta-analysis of randomised controlled trials.锌制剂预防或治疗成人急性病毒性呼吸道感染：随机对照试验的快速系统评价和荟萃分析。
BMJ Open. 2021 Nov 2;11(11):e047474. doi: 10.1136/bmjopen-2020-047474.

本文引用的文献

1
Histopathology and genetic susceptibility in COVID-19 pneumonia.COVID-19 肺炎的组织病理学和遗传易感性。
Eur J Clin Invest. 2020 Jul;50(7):e13259. doi: 10.1111/eci.13259. Epub 2020 Jun 27.
2
The continuing evolution of COVID-19 imaging pathways in the UK: a British Society of Thoracic Imaging expert reference group update.英国COVID-19成像路径的持续演变：英国胸科影像学会专家参考小组更新
Clin Radiol. 2020 Jun;75(6):399-404. doi: 10.1016/j.crad.2020.04.002. Epub 2020 Apr 15.
3
Clinical features of covid-19.新型冠状病毒肺炎的临床特征。
BMJ. 2020 Apr 17;369:m1470. doi: 10.1136/bmj.m1470.
4
Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence.免疫抑制与刺激药物和新型冠状病毒肺炎之间的关联——当前证据的系统评价
Ecancermedicalscience. 2020 Mar 27;14:1022. doi: 10.3332/ecancer.2020.1022. eCollection 2020.
5
Pulmonary capillary leak syndrome after influenza A (H1N1) virus infection.
Am J Emerg Med. 2010 Nov;28(9):1063.e1-6. doi: 10.1016/j.ajem.2010.01.033. Epub 2010 May 4.
6
Overview of antiviral and anti-inflammatory treatment for severe acute respiratory syndrome.重症急性呼吸综合征的抗病毒与抗炎治疗概述
Expert Rev Anti Infect Ther. 2005 Apr;3(2):251-62. doi: 10.1586/14787210.3.2.251.